Cargando…
The utility of SARS‐CoV‐2 nucleocapsid protein in laboratory diagnosis
BACKGROUND: The Coronavirus Disease 2019 (COVID‐19) is caused by the severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), which has now become a global pandemic owing to its high transmissibility. The SARS‐CoV‐2 nucleocapsid protein tests are playing an important role in screening and diagn...
Autores principales: | Li, Xinwei, Xiong, Mengyuan, Deng, Qiaoling, Guo, Xiaobing, Li, Yirong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9279953/ https://www.ncbi.nlm.nih.gov/pubmed/35657146 http://dx.doi.org/10.1002/jcla.24534 |
Ejemplares similares
-
The Utility of Specific Antibodies Against SARS-CoV-2 in Laboratory Diagnosis
por: Fu, Yu, et al.
Publicado: (2021) -
Electrostatic features for nucleocapsid proteins of SARS-CoV and SARS-CoV-2
por: Guo, Wenhan, et al.
Publicado: (2021) -
The Epitope Study on the SARS-CoV Nucleocapsid Protein
por: Li, Shuting, et al.
Publicado: (2003) -
Early Laboratory Diagnosis of COVID-19 by Antigen Detection in Blood Samples of the SARS-CoV-2 Nucleocapsid Protein
por: Thudium, Rebekka F., et al.
Publicado: (2021) -
Re: Profile of specific antibodies to SARS-CoV-2: The first report
por: Zeng, Zhikun, et al.
Publicado: (2020)